株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

アップストリームバイオプロセッシングの世界市場:規模、シェアおよび動向 - 製品、ワークフロー、使用タイプ、モード、セグメント別予測(2019年~2026年)

Upstream Bioprocessing Market Size, Share & Trends Analysis Report By Product (Bioreactors, Cell Culture), By Workflow, By Use Type, By Mode (In House, Outsourced), And Segment Forecasts, 2019 - 2026

発行 Grand View Research, Inc. 商品コード 913839
出版日 ページ情報 英文 145 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=110.43円で換算しております。
Back to Top
アップストリームバイオプロセッシングの世界市場:規模、シェアおよび動向 - 製品、ワークフロー、使用タイプ、モード、セグメント別予測(2019年~2026年) Upstream Bioprocessing Market Size, Share & Trends Analysis Report By Product (Bioreactors, Cell Culture), By Workflow, By Use Type, By Mode (In House, Outsourced), And Segment Forecasts, 2019 - 2026
出版日: 2019年09月25日 ページ情報: 英文 145 Pages
概要

世界のアップストリームバイオプロセッシング市場は、2019年から2026年の間に12.9%のCAGRで拡大する見通しで、2026年には126億米ドルに達すると予測されています。

当レポートは世界のアップストリームバイオプロセッシング市場について調査しており、市場の動向や見通し、製品・ワークフロー・使用タイプ・モード・地域別の市場分析、競合情勢、主要企業のプロファイル等の情報を提供しています。

目次

第1章 エグゼクティブサマリー

  • 市場の見通し
  • セグメントの見通し
  • 競合の洞察

第2章 調査方法

  • 情報調達
  • 情報またはデータ分析
  • 市場の定式化および検証

第3章 市場変数、動向、範囲

  • 産業ピラミッド分析
  • 製品の普及率/成長の見通しのマッピング(2018年)
  • 技術概要
  • 市場力学
  • ビジネス環境分析
  • 市場参入戦略

第4章 市場分析:製品別

  • 動向分析
  • バイオリアクター/発酵槽
  • 細胞培養製品
  • フィルター
  • バイオリアクターアクセサリー
  • バッグ・コンテナ
  • その他

第5章 市場分析:ワークフロー別

  • 動向分析
  • 培地の準備
  • 細胞培養
  • 細胞分離

第6章 市場分析:使用タイプ別

  • 動向分析
  • 多用途
  • 使い捨て

第7章 市場分析:モード別

  • 動向分析
  • 社内
  • アウトソーシング

第8章 市場分析:地域別(製品・ワークフロー・使用タイプ・モード別)

  • 市場シェア(2018年・2026年)
  • 北米
  • 欧州
  • アジア太平洋地域
  • ラテンアメリカ
  • 中東・アフリカ(MEA)

第9章 競合情勢

  • 企業の分類
  • 最近の開発および影響分析:主要市場参入企業
  • 公開会社
  • 民間企業
  • 戦略の枠組み
  • 企業プロファイル
図表

List of Tables

  • TABLE 1 North America upstream bioprocessing market estimates & forecasts, by product, 2015 - 2026 (USD Million)
  • TABLE 2 North America upstream bioprocessing market estimates & forecasts, by workflow, 2015 - 2026 (USD Million)
  • TABLE 3 North America upstream bioprocessing market estimates & forecasts, by use type, 2015 - 2026 (USD Million)
  • TABLE 4 North America upstream bioprocessing market estimates & forecasts, by mode, 2015 - 2026 (USD Million)
  • TABLE 5 U.S. upstream bioprocessing market estimates & forecasts, by product, 2015 - 2026 (USD Million)
  • TABLE 6 U.S. upstream bioprocessing market estimates & forecasts, by workflow, 2015 - 2026 (USD Million)
  • TABLE 7 U.S upstream bioprocessing market estimates & forecasts, by use type, 2015 - 2026 (USD Million)
  • TABLE 8 U.S. upstream bioprocessing market estimates & forecasts, by mode, 2015 - 2026 (USD Million)
  • TABLE 9 Canada upstream bioprocessing market estimates & forecasts, by product, 2015 - 2026 (USD Million)
  • TABLE 10 Canada upstream bioprocessing market estimates & forecasts, by workflow, 2015 - 2026 (USD Million)
  • TABLE 11 Canada upstream bioprocessing market estimates & forecasts, by use type, 2015 - 2026 (USD Million)
  • TABLE 12 Canada upstream bioprocessing market estimates & forecasts, by mode, 2015 - 2026 (USD Million)
  • TABLE 13 Europe upstream bioprocessing market estimates & forecasts, by product, 2015 - 2026 (USD Million)
  • TABLE 14 Europe upstream bioprocessing market estimates & forecasts, by workflow, 2015 - 2026 (USD Million)
  • TABLE 15 Europe upstream bioprocessing market estimates & forecasts, by use type, 2015 - 2026 (USD Million)
  • TABLE 16 Europe upstream bioprocessing market estimates & forecasts, by mode, 2015 - 2026 (USD Million)
  • TABLE 17 Germany upstream bioprocessing market estimates & forecasts, by product, 2015 - 2026 (USD Million)
  • TABLE 18 Germany upstream bioprocessing market estimates & forecasts, by workflow, 2015 - 2026 (USD Million)
  • TABLE 19 Germany upstream bioprocessing market estimates & forecasts, by use type, 2015 - 2026 (USD Million)
  • TABLE 20 Germany upstream bioprocessing market estimates & forecasts, by mode, 2015 - 2026 (USD Million)
  • TABLE 21 France upstream bioprocessing market estimates & forecasts, by product, 2015 - 2026 (USD Million)
  • TABLE 22 France upstream bioprocessing market estimates & forecasts, by workflow, 2015 - 2026 (USD Million)
  • TABLE 23 France upstream bioprocessing market estimates & forecasts, by use type, 2015 - 2026 (USD Million)
  • TABLE 24 France upstream bioprocessing market estimates & forecasts, by mode, 2015 - 2026 (USD Million)
  • TABLE 25 Single-use technology landscape in Asian countries
  • TABLE 26 Asia Pacific upstream bioprocessing market estimates & forecasts, by product, 2015 - 2026 (USD Million)
  • TABLE 27 Asia Pacific upstream bioprocessing market estimates & forecasts, by workflow, 2015 - 2026 (USD Million)
  • TABLE 28 Asia Pacific upstream bioprocessing market estimates & forecasts, by use type, 2015 - 2026 (USD Million)
  • TABLE 29 Asia Pacific upstream bioprocessing market estimates & forecasts, by mode, 2015 - 2026 (USD Million)
  • TABLE 30 China upstream bioprocessing market estimates & forecasts, by product, 2015 - 2026 (USD Million)
  • TABLE 31 China upstream bioprocessing market estimates & forecasts, by workflow, 2015 - 2026 (USD Million)
  • TABLE 32 China upstream bioprocessing market estimates & forecasts, by use type, 2015 - 2026 (USD Million)
  • TABLE 33 China upstream bioprocessing market market estimates & forecasts, by mode, 2015 - 2026 (USD Million)
  • TABLE 34 India upstream bioprocessing market estimates & forecasts, by product, 2015 - 2026 (USD Million)
  • TABLE 35 India upstream bioprocessing market estimates & forecasts, by workflow, 2015 - 2026 (USD Million)
  • TABLE 36 India upstream bioprocessing market estimates & forecasts, by use type, 2015 - 2026 (USD Million)
  • TABLE 37 India upstream bioprocessing market market estimates & forecasts, by mode, 2015 - 2026 (USD Million)
  • TABLE 38 Latin America upstream bioprocessing market estimates & forecasts, by product, 2015 - 2026 (USD Million)
  • TABLE 39 Latin America upstream bioprocessing market estimates & forecasts, by workflow, 2015 - 2026 (USD Million)
  • TABLE 40 Latin America upstream bioprocessing market estimates & forecasts, by use type, 2015 - 2026 (USD Million)
  • TABLE 41 Latin America upstream bioprocessing market estimates & forecasts, by mode, 2015 - 2026 (USD Million)
  • TABLE 42 Brazil upstream bioprocessing market estimates & forecasts, by product, 2015 - 2026 (USD Million)
  • TABLE 43 Brazil upstream bioprocessing market estimates & forecasts, by workflow, 2015 - 2026 (USD Million)
  • TABLE 44 Brazil upstream bioprocessing market estimates & forecasts, by use type, 2015 - 2026 (USD Million)
  • TABLE 45 Brazil upstream bioprocessing market market estimates & forecasts, by mode, 2015 - 2026 (USD Million)
  • TABLE 46 MEA upstream bioprocessing market estimates & forecasts, by product, 2015 - 2026 (USD Million)
  • TABLE 47 MEA upstream bioprocessing market estimates & forecasts, by workflow, 2015 - 2026 (USD Million)
  • TABLE 48 MEA upstream bioprocessing market estimates & forecasts, by use type, 2015 - 2026 (USD Million)
  • TABLE 49 MEA upstream bioprocessing market estimates & forecasts, by mode, 2015 - 2026 (USD Million)
  • TABLE 50 South Africa upstream bioprocessing market estimates & forecasts, by product, 2015 - 2026 (USD Million)
  • TABLE 51 South Africa upstream bioprocessing market estimates & forecasts, by workflow, 2015 - 2026 (USD Million)
  • TABLE 52 South Africa upstream bioprocessing market estimates & forecasts, by use type, 2015 - 2026 (USD Million)
  • TABLE 53 South Africa upstream bioprocessing market estimates & forecasts, by mode, 2015 - 2026 (USD Million)
  • TABLE 54 List of private companies

List of Figures

  • FIG. 1 Market segmentation & scope
  • FIG. 2 Market summary
  • FIG. 3 Market research process
  • FIG. 4 Information procurement
  • FIG. 5 Primary research pattern
  • FIG. 6 Market research approaches
  • FIG. 7 Value chain based sizing & forecasting
  • FIG. 8 QFD modelling for market share assessment
  • FIG. 9 Industry pyramid analysis
  • FIG. 10 Penetration & growth prospect mapping for product, 2018
  • FIG. 11 Market trends & outlook
  • FIG. 12 Market driver relevance analysis (Current & future impact)
  • FIG. 13 Capital expenditure comparison between Single-Use Technology (SUT) and Stainless Steel (SS)-based biologic manufacturing
  • FIG. 14 Market restraint relevance analysis (Current & future impact)
  • FIG. 15 Porter's Five Forces analysis
  • FIG. 16 SWOT Analysis, By Factor (political & legal, economic and technological)
  • FIG. 17 Upstream bioprocessing market: Product outlook key takeaways
  • FIG. 18 Upstream bioprocessing market: Product movement analysis
  • FIG. 19 Global bioreactors/ fermenters market, 2015 - 2026 (USD Million)
  • FIG. 20 Global cell culture products market, 2015 - 2026 (USD Million)
  • FIG. 21 Global upstream bioprocessing filters market, 2015 - 2026 (USD Million)
  • FIG. 22 Global bioreactors accessories market, 2015-2026 (USD Million)
  • FIG. 23 Global bags & containers market, 2015-2026 (USD Million)
  • FIG. 24 Global other upstream bioprocessing products market, 2015-2026 (USD Million)
  • FIG. 25 Upstream bioprocessing market: Workflow outlook key takeaways
  • FIG. 26 Upstream bioprocessing market: Workflow movement analysis
  • FIG. 27 Global media preparation market, 2015 - 2026 (USD Million)
  • FIG. 28 Global cell culture market, 2015 - 2026 (USD Million)
  • FIG. 29 Global cell separation market, 2015 - 2026 (USD Million)
  • FIG. 30 Upstream bioprocessing market: Use type outlook key takeaways
  • FIG. 31 Upstream bioprocessing market: Use type movement analysis
  • FIG. 32 Global multi-use upstream bioprocessing market, 2015 - 2026 (USD Million)
  • FIG. 33 Global single-use upstream bioprocessing market, 2015 - 2026 (USD Million)
  • FIG. 34 Upstream bioprocessing market: Mode outlook key takeaways
  • FIG. 35 Upstream bioprocessing market: Mode movement analysis
  • FIG. 36 Global in-house upstream bioprocessing market, 2015 - 2026 (USD Million)
  • FIG. 37 Global outsourced upstream bioprocessing market, 2015 - 2026 (USD Million)
  • FIG. 38 Regional market place: Key takeaway
  • FIG. 39 Upstream bioprocessing regional outlook, 2018 & 2026
  • FIG. 40 North America upstream bioprocessing market, 2015 - 2026 (USD Million)
  • FIG. 41 U.S. upstream bioprocessing market, 2015 - 2026 (USD Million)
  • FIG. 42 Canada upstream bioprocessing market, 2015 - 2026 (USD Million)
  • FIG. 43 Europe upstream bioprocessing market, 2015 - 2026 (USD Million)
  • FIG. 44 Germany upstream bioprocessing market, 2015 - 2026 (USD Million)
  • FIG. 45 France upstream bioprocessing market, 2015 - 2026 (USD Million)
  • FIG. 46 Asia Pacific upstream bioprocessing market, 2015 - 2026 (USD Million)
  • FIG. 47 China upstream bioprocessing market, 2015 - 2026 (USD Million)
  • FIG. 48 India upstream bioprocessing market, 2015 - 2026 (USD Million)
  • FIG. 49 Latin America upstream bioprocessing market, 2015-2026 (USD Million)
  • FIG. 50 Brazil upstream bioprocessing market, 2015 - 2026 (USD Million)
  • FIG. 51 Middle East & Africa upstream bioprocessing market, 2015 - 2026 (USD Million)
  • FIG. 52 South Africa upstream bioprocessing market, 2015 - 2026 (USD Million)
  • FIG. 53 Company categorization
  • FIG. 54 Impact analysis by key companies
  • FIG. 55 Market position analysis for public companies
  • FIG. 56 Strategy framework
目次
Product Code: GVR-3-68038-592-2

The global upstream bioprocessing market size is expected to reach USD 12.60 billion by 2026, expanding at a CAGR of 12.90% during the forecast period, according to a new report by Grand View Research, Inc. Commercial success and wide acceptance of biopharmaceuticals have provided lucrative growth avenues to several in house as well as contract manufacturing biopharmaceutical companies. Furthermore, a confluence of factors, such as high demand for biosimilars and biologics, launch of improved cost-effective technologies, and growing acceptance of single-use systems have driven the revenue performance of the market.

Start-ups and new market entrants often face budget constraints while establishing new biomanufacturing plants. Thus, these entities expand their biotherapeutics portfolio by outsourcing the production process to contract services, thereby aiding in revenue growth for upstream bioprocessing services.

Continuous upstream bioprocessing has greatly benefited the bioprocessing industry. Rising implementation of methods, such as acoustic wave technology and continuous centrifugation, for clarification of bioreactor cultures tends to minimize the clarification burden. This, in turn, increases the cell-culture densities, consequently resulting in efficient upstream processes.

Ongoing advancements in cell line productivity with respect to protein expression and clone screening are expected to result in the fastest CAGR of cell culture products over the forecast period. Cell culture is considered as the most challenging and crucial step in upstream bioprocessing, and thus demands more attention with respect to technological intricacies, resulting in the largest share in the upstream bioprocessing market.

Factors such as multi-use systems incur one-time investment, are applicable for larger bioprocessing volumes and maintain the pH and oxygen accurately resulting in high usage rate of these systems. However, a paradigm shift from conventional stainless-steel bioreactors to single-use bioreactor systems has attributed to the lucrative growth of the single-use segment.

Key market players are adopting strategic initiatives, such as novel product developments, mutually beneficial partnerships, agreements, and geographical expansion to reinforce their market presence. For instance, in February 2019, Danaher Corporation signed an agreement to acquire the Biopharma business of GE Life Sciences. The acquisition broadened Danaher's market presence with the addition of GE Biopharma's cell culture media, single-use technologies, development instrumentation, and consumables to its existing portfolio.

Further key findings from the report suggest:

  • High availability of bioreactors and continuous launches of single-use bioreactors by the key market players can be attributed to the remarkable revenue share of the bioreactors segment
  • Presence of well-established biopharmaceutical manufacturing firms capable of performing in-house bioproduction has led to the maximum revenue share of this segment
  • Outsourced mode of upstream bioprocessing is anticipated to witness the fastest CAGR over the forecast period, owing to increase in investments and expansion of manufacturing capabilities through the integration of single-use systems in the plants by CMOs
  • North America dominated the global upstream bioprocessing market as a result of the continuous innovations in biotechnology and rising preferences for biopharmaceuticals in the region. Moreover, the presence of substantial in-house biopharmaceutical manufacturers coupled with numerous investments in the U.S. biologics market has driven the growth
  • Asia Pacific is poised to witness the fastest CAGR over the forecast period due to growing awareness about the rapid analytical methods that can be used for in-process control during the upstream workflows

Table of Contents

Chapter 1 Executive Summary

  • 1.1 Upstream Bioprocessing Market: Market Outlook
  • 1.2 Upstream Bioprocessing Market: Segment Outlook
  • 1.3 Upstream Bioprocessing Market: Competitive Insights

Chapter 2 Research Methodology

  • 2.1 Information Procurement
  • 2.2 Information or Data Analysis
  • 2.3 Market Formulation & Validation

Chapter 3 Market Variables, Trends& Scope

  • 3.1 Industry Pyramid Analysis
  • 3.2 Penetration & Growth Prospect Mapping for Product, 2018
  • 3.3 Upstream Bioprocessing: Technology Overview
  • 3.4 Upstream Bioprocessing Market: Market Dynamics
    • 3.4.1 Market driver analysis
      • 3.4.1.1 Rising adoption of single-use upstream bioprocessing
      • 3.4.1.2 Commercial success and rising demand for biotherapeutics
      • 3.4.1.3 Rising competition among the market vendors
    • 3.4.2 Market restraint analysis
      • 3.4.2.1 Budget constraints for small & emerging players
      • 3.4.2.2 Operational challenges pertaining to upstream bioprocessing
    • 3.4.3 Market challenges
      • 3.4.3.1 Environmental challenges pertaining to the usage of single-use systems
  • 3.5 Business Environment Analysis: Upstream Bioprocessing Market
    • 3.5.1 Industry analysis - Porter's
      • 3.5.1.1 Supplier power
      • 3.5.1.2 Buyer power
      • 3.5.1.3 Substitution threat
      • 3.5.1.4 Threat from new entrant
      • 3.5.1.5 Competitive rivalry
    • 3.5.2 Upstream bioprocessing market: SWOT analysis, By factor (political & legal, economic and technological)
    • 3.5.3 Major deals & strategic alliances analysis
      • 3.5.3.1 Agreement
      • 3.5.3.2 Technology collaborations
      • 3.5.3.3 Merger & acquisition
      • 3.5.3.4 Licensing & partnership
  • 3.6 Market Entry Strategies

Chapter 4 Upstream Bioprocessing Market Categorization: Product Estimates & Trend Analysis

  • 4.1 Upstream Bioprocessing Market: Product Movement Analysis
  • 4.2 Bioreactors/ Fermenters
    • 4.2.1 Global bioreactors/ fermenters market, 2015 - 2026 (USD Million)
  • 4.3 Cell Culture Products
    • 4.3.1 Global cell culture products market, 2015 - 2026 (USD Million)
  • 4.4 Filters
    • 4.4.1 Global upstream bioprocessing filters market, 2015 - 2026 (USD Million)
  • 4.5 Bioreactors Accessories
    • 4.5.1 Global bioreactors accessories market, 2015 - 2026 (USD Million)
  • 4.6 Bags & Containers
    • 4.6.1 Global bags & containers market, 2015 - 2026 (USD Million)
  • 4.7 Others
    • 4.7.1 Global other upstream bioprocessing products market, 2015 - 2026 (USD Million)

Chapter 5 Upstream Bioprocessing Market Categorization: Workflow Estimates & Trend Analysis

  • 5.1 Upstream Bioprocessing Market: Workflow Movement Analysis
  • 5.2 Media Preparation
    • 5.2.1 Global media preparation market, 2015 - 2026 (USD Million)
  • 5.3 Cell Culture
    • 5.3.1 Global cell culture market, 2015 - 2026 (USD Million)
  • 5.4 Cell Separation
    • 5.4.1 Global cell separation market, 2015 - 2026 (USD Million)

Chapter 6 Upstream Bioprocessing Market Categorization: Use Type Estimates & Trend Analysis

  • 6.1 Upstream Bioprocessing Market: Use Type Movement Analysis
  • 6.2 Multi-use
    • 6.2.1 Global multi-use upstream bioprocessing market, 2015 - 2026 (USD Million)
  • 6.3 Single-use
    • 6.3.1 Global single-use upstream bioprocessing market, 2015 - 2026 (USD Million)

Chapter 7 Upstream Bioprocessing Market Categorization: Mode Estimates & Trend Analysis

  • 7.1 Upstream Bioprocessing Market: Mode Movement Analysis
  • 7.2 In-house
    • 7.2.1 Global in-house upstream bioprocessing market, 2015 - 2026 (USD Million)
  • 7.3 Outsourced
    • 7.3.1 Global outsourced upstream bioprocessing market, 2015 - 2026 (USD Million)

Chapter 8 Upstream Bioprocessing Market Categorization: Regional Estimates & Trend Analysis, by Product, Workflow, Use Type & Mode

  • 8.1 Upstream Bioprocessing Market Share By Region, 2018 & 2026
  • 8.2 North America
    • 8.2.1 North America upstream bioprocessing market, 2015 - 2026 (USD Million)
    • 8.2.2 U.S.
      • 8.2.2.1 U.S. upstream bioprocessing market, by product, 2015 - 2026 (USD Million)
      • 8.2.2.2 U.S. upstream bioprocessing market, by workflow, 2015 - 2026 (USD Million)
      • 8.2.2.3 U.S. upstream bioprocessing market, by use-type, 2015 - 2026 (USD Million)
      • 8.2.2.4 U.S. upstream bioprocessing market, by mode, 2015 - 2026 (USD Million)
    • 8.2.3 Canada
      • 8.2.3.1 Canada upstream bioprocessing market, by product, 2015 - 2026 (USD Million)
      • 8.2.3.2 Canada upstream bioprocessing market, by workflow, 2015 - 2026 (USD Million)
      • 8.2.3.3 Canada upstream bioprocessing market, by use-type, 2015 - 2026 (USD Million)
      • 8.2.3.4 Canada upstream bioprocessing market, by mode, 2015 - 2026 (USD Million)
  • 8.3 Europe
    • 8.3.1 Europe upstream bioprocessing market, 2015 - 2026 (USD Million)
    • 8.3.2 Germany
      • 8.3.2.1 Germany upstream bioprocessing market, by product, 2015 - 2026 (USD Million)
      • 8.3.2.2 Germany upstream bioprocessing market, by workflow, 2015 - 2026 (USD Million)
      • 8.3.2.3 Germany upstream bioprocessing market, by use-type, 2015 - 2026 (USD Million)
      • 8.3.2.4 Germany upstream bioprocessing market, by mode, 2015 - 2026 (USD Million)
    • 8.3.3 France
      • 8.3.3.1 France upstream bioprocessing market, by product, 2015 - 2026 (USD Million)
      • 8.3.3.2 France upstream bioprocessing market, by workflow, 2015 - 2026 (USD Million)
      • 8.3.3.3 France upstream bioprocessing market, by use-type, 2015 - 2026 (USD Million)
      • 8.3.3.4 France upstream bioprocessing market, by mode, 2015 - 2026 (USD Million)
  • 8.4 Asia Pacific
    • 8.4.1 Asia Pacific upstream bioprocessing market, 2015 - 2026 (USD Million)
    • 8.4.2 China
      • 8.4.2.1 China upstream bioprocessing market, by product, 2015 - 2026 (USD Million)
      • 8.4.2.2 China upstream bioprocessing market, by workflow, 2015 - 2026 (USD Million)
      • 8.4.2.3 China upstream bioprocessing market, by use-type, 2015 - 2026 (USD Million)
      • 8.4.2.4 China upstream bioprocessing market, by mode, 2015 - 2026 (USD Million)
    • 8.4.3 India
      • 8.4.3.1 India upstream bioprocessing market, by product, 2015 - 2026 (USD Million)
      • 8.4.3.2 India upstream bioprocessing market, by workflow, 2015 - 2026 (USD Million)
      • 8.4.3.3 India upstream bioprocessing market, by use-type, 2015 - 2026 (USD Million)
      • 8.4.3.4 India upstream bioprocessing market, by mode, 2015 - 2026 (USD Million)
  • 8.5 Latin America
    • 8.5.1 Latin America upstream bioprocessing market, 2015 - 2026 (USD Million)
    • 8.5.2 Brazil
      • 8.5.2.1 Brazil upstream bioprocessing market, by product, 2015 - 2026 (USD Million)
      • 8.5.2.2 Brazil upstream bioprocessing market, by workflow, 2015 - 2026 (USD Million)
      • 8.5.2.3 Brazil upstream bioprocessing market, by use-type, 2015 - 2026 (USD Million)
      • 8.5.2.4 Brazil upstream bioprocessing market, by mode, 2015 - 2026 (USD Million)
  • 8.6 Middle East & Africa (MEA)
    • 8.6.1 Middle East & Africa upstream bioprocessing market, 2015 - 2026 (USD Million)
    • 8.6.2 South Africa
      • 8.6.2.1 South Africa upstream bioprocessing market, by product, 2015 - 2026 (USD Million)
      • 8.6.2.2 South Africa upstream bioprocessing market, by workflow, 2015 - 2026 (USD Million)
      • 8.6.2.3 South Africa upstream bioprocessing market, by use-type, 2015 - 2026 (USD Million)
      • 8.6.2.4 South Africa upstream bioprocessing market, by mode, 2015 - 2026 (USD Million)

Chapter 9 Competitive Landscape

  • 9.1 Company Categorization
  • 9.2 Recent Developments & Impact Analysis, by Key Market Participants
  • 9.3 Public Companies
    • 9.3.1 Company market position analysis
  • 9.4 Private Companies
    • 9.4.1 List of key emerging companies/ innovators
  • 9.5 Strategy Framework
  • 9.6 Company Profiles
    • 9.6.1 GE Healthcare
      • 9.6.1.1 Company overview
      • 9.6.1.2 Financial performance
      • 9.6.1.3 Product benchmarking
      • 9.6.1.4 Strategic initiatives
    • 9.6.2 Thermo Fisher Scientific Inc.
      • 9.6.2.1 Company overview
      • 9.6.2.2 Finesse
      • 9.6.2.2.1 Company overview
      • 9.6.2.3 Patheon
      • 9.6.2.3.1 Company overview
      • 9.6.2.2 Financial performance
      • 9.6.2.3 Product benchmarking
      • 9.6.2.4 Strategic initiatives
    • 9.6.3 Merck KGaA
      • 9.6.3.1 Company overview
      • 9.6.3.2 Financial performance
      • 9.6.3.3 Product benchmarking
      • 9.6.3.4 Strategic initiatives
    • 9.6.4 Corning, Inc.
      • 9.6.4.1 Company overview
      • 9.6.4.2 Financial performance
      • 9.6.4.3 Product benchmarking
      • 9.6.4.4 Strategic initiatives
    • 9.6.5 Sartorius AG
      • 9.6.5.1 Company overview
      • 9.6.5.2 Financial performance
      • 9.6.5.3 Product benchmarking
      • 9.6.5.4 Strategic initiatives
    • 9.6.6 Eppendorf AG
      • 9.6.6.1 Company overview
      • 9.6.6.2 Financial performance
      • 9.6.6.3 Product benchmarking
      • 9.6.6.4 Strategic initiatives
    • 9.6.7 Danaher Corporation
      • 9.6.7.1 Company overview
      • 9.6.7.2 Pall Corporation
      • 9.6.7.2.1 Company overview
      • 9.6.7.3 Financial performance
      • 9.6.7.4 Product benchmarking
      • 9.6.7.5 Strategic initiatives
    • 9.6.8 Boehringer Ingelheim GmbH
      • 9.6.8.1 Company overview
      • 9.6.8.2 Financial performance
      • 9.6.8.3 Product benchmarking
      • 9.6.8.4 Strategic initiatives
    • 9.6.9 Applikon Biotechnology
      • 9.6.9.1 Company overview
      • 9.6.9.2 Financial performance
      • 9.6.9.3 Product benchmarking
      • 9.6.9.4 Strategic initiatives
    • 9.6.10 PBS Biotech, Inc.
      • 9.6.10.1 Company overview
      • 9.6.10.2 Financial performance
      • 9.6.10.3 Product benchmarking
      • 9.6.10.4 Strategic initiatives
    • 9.6.11 Lonza
      • 9.6.11.1 Company overview
      • 9.6.11.2 Financial performance
      • 9.6.11.3 Product benchmarking
      • 9.6.11.4 Strategic initiatives
    • 9.6.12 CellGenix GmbH
      • 9.6.12.1 Company overview
      • 9.6.12.2 Financial performance
      • 9.6.12.3 Product benchmarking
      • 9.6.12.4 Strategic initiatives
    • 9.6.13 Samsung BioLogics
      • 9.6.13.1 Company overview
      • 9.6.13.2 Financial performance
      • 9.6.13.3 Product benchmarking
      • 9.6.13.4 Strategic initiatives
    • 9.6.14 AGC Inc.
      • 9.6.14.1 Company overview
      • 9.6.14.2 CMC Biologics
      • 9.6.14.2.1 Company overview
      • 9.6.14.3 Financial performance
      • 9.6.14.4 Product benchmarking
      • 9.6.14.5 Strategic initiatives
    • 9.6.15 VWR International, LLC
      • 9.6.15.1 Company overview
      • 9.6.15.2 JM BIOCONNECT
      • 9.6.15.2.1 Company overview
      • 9.6.15.3 Financial performance
      • 9.6.15.4 Product benchmarking
      • 9.6.15.5 Strategic initiatives
Back to Top